Your browser doesn't support javascript.
loading
Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas.
García-Álvarez, María; Alonso-Álvarez, Sara; Prieto-Conde, Isabel; Jiménez, Cristina; Sarasquete, M Eugenia; Chillón, M Carmen; Medina, Alejandro; Balanzategui, Ana; Maldonado, Rebeca; Antón, Alicia; Puig, Noemí; Rodríguez, Marta; Blanco, Oscar; Tamayo, Pilar; González-Calle, Verónica; Martín, Alejandro; García-Sanz, Ramón; González, Marcos; Caballero, M Dolores; Alcoceba, Miguel.
Affiliation
  • García-Álvarez M; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Alonso-Álvarez S; Department of Hematology, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
  • Prieto-Conde I; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Jiménez C; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Sarasquete ME; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Chillón MC; Biomedical Research Networking Centre - Oncology (CIBERONC), Madrid, Spain.
  • Medina A; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Balanzategui A; Biomedical Research Networking Centre - Oncology (CIBERONC), Madrid, Spain.
  • Maldonado R; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Antón A; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Puig N; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Rodríguez M; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Blanco O; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Tamayo P; Biomedical Research Networking Centre - Oncology (CIBERONC), Madrid, Spain.
  • González-Calle V; Department of Pathology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Martín A; Department of Pathology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • García-Sanz R; Department of Nuclear Medicine, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • González M; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Caballero MD; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain.
  • Alcoceba M; Biomedical Research Networking Centre - Oncology (CIBERONC), Madrid, Spain.
Blood Cancer J ; 9(7): 52, 2019 06 17.
Article in En | MEDLINE | ID: mdl-31209206
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Variable Region / Gene Rearrangement, B-Lymphocyte, Heavy Chain / Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse / Genes, Immunoglobulin Heavy Chain Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2019 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Variable Region / Gene Rearrangement, B-Lymphocyte, Heavy Chain / Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse / Genes, Immunoglobulin Heavy Chain Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2019 Type: Article Affiliation country: Spain